CryptoPS test – rapid and precise antigen detection for Cryptococcus infection
BIOSYNEX CryptoPS is a rapid, semi-quantitative Cryptococcus test for professional use. The test is used to detect Cryptococcus sp. capsular antigens in serum, plasma, whole blood and cerebrospinal fluid (CSF), and supports rapid diagnosis of cryptococcal meningitis in immunocompromised patients, including those who are HIV-positive and organ transplant recipients.
CryptoPS uses advanced lateral flow technology
Using antibodies targeting the capsule of Cryptococcus, CryptoPS detects both low and high antigen levels (T1 and T2). The T2 line serves as an indicator of high risk and the need for rapid intervention. See also our CRP test and other infection-related tests.
The test is easy to integrate into clinical workflows
CryptoPS does not require advanced laboratory infrastructure. Results are read visually after just 10 minutes, and the test includes both internal quality control and the option for titer determination. Suitable for infectious disease departments, emergency departments and outpatient clinics.
Clinically validated with high accuracy
CryptoPS is CE-marked and has documented high sensitivity and specificity in several independent studies. The test shows no cross-reactivity with related fungal infections and supports rapid clinical decision-making.
FAQ – BIOSYNEX CryptoPS test
What is CryptoPS used for?
CryptoPS is used for rapid and semi-quantitative detection of Cryptococcus sp. capsular antigens when cryptococcal meningitis is suspected.
Which samples can be used?
Capillary blood, venous blood, serum, plasma, and cerebrospinal fluid can be used with the CryptoPS test.
What does the T2 line indicate?
The T2 line indicates a high concentration of antigens and should lead to follow-up treatment and possibly lumbar puncture.
What are the benefits of CryptoPS?
It combines high accuracy, rapid turnaround time, ease of use and the option for titre determination – all without the need for laboratory equipment.
